We recently published a list of 10 Stocks Wall Street Is Calling Bullish Amid Market Turmoil. In this article, we are going ...

Novo Nordisk is reorganizing its research and early development unit in an effort to “future-proof the organization” and ...

Novo Nordisk may be reorganizing its early-stage R&D capabilities, but the Danish pharma’s chief scientific officer has insisted that the changes aren’t primarily about laying off staff. | Novo ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Roche agreed to develop a weight-loss drug with Danish biotech Zealand Pharma, pressuring Novo Nordisk and Eli Lilly.

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its ...

Gift 5 articles to anyone you choose each month when you subscribe. Danish pharmaceutical giant Novo Nordisk says about 13 million Australians are living with obesity or are overweight ...

Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a $10 billion purchase. Walgreens Boots rose 5.6% in after hours trading on ...

Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, during a session at India Today Conclave 2025, said that many celebrities may not want to admit to taking ...

At India Today Conclave 2025, Vikrant Shrotriya, Managing Director of Novo Nordisk India, said that a weight-loss drug is not a magic pill. Instead, it is a medicine that works alongside diet and ...

The CEO of <strong>Novo Nordisk</strong> warned of the impact of tariffs on the pharmaceutical industry. Weight-loss drugs, including Ozempic and Wegovy, could cost ...